11 participants
Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-23
- Start Date:
- 2019-12-31
- Completion:
- 2023-09-26
Conditions
- Acute Myeloid Leukemia
Interventions
- DRUG
- OTHER